Related Experiment Videos
Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat
1Department of Mental Health, The Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Rd., Belfast BT9 7BL, UK. m.cahir@qub.ac.uk
Summary
All tested antipsychotics bind to alpha1A- and alpha1B-adrenoceptors. This binding may contribute to the therapeutic effects of atypical antipsychotics and some typical antipsychotics.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Antipsychotics are crucial for treating psychosis.
- Understanding their receptor binding profiles is key to optimizing efficacy and minimizing side effects.
- Alpha-1 adrenoceptors are potential targets for antipsychotic action.
Purpose of the Study:
- To determine the affinity of typical and atypical antipsychotics for alpha1A- and alpha1B-adrenoceptors.
- To assess the selectivity of these antipsychotics for alpha-1 adrenoceptor subtypes.
- To explore the potential contribution of alpha-1 adrenoceptor blockade to antipsychotic activity.
Main Methods:
- Competition binding assays were performed.
- Alpha1A- and alpha1B-adrenoceptors were studied in rat submaxillary gland and liver tissues.
- Antipsychotic affinities (K(i)s) were measured.
Main Results:
- All examined antipsychotics demonstrated relatively high affinity for both alpha1A- and alpha1B-adrenoceptors (K(i)s < 74 nM).
- No antipsychotic exhibited significant selectivity (>10-fold) for either subtype.
- Comparison with dopamine D2 receptor affinities suggests a role for alpha-1 adrenoceptor blockade.
Conclusions:
- Both typical and atypical antipsychotics interact with alpha1A- and alpha1B-adrenoceptors.
- This interaction may contribute to the overall antipsychotic efficacy of these drugs.
- Further research into selective alpha-1 adrenoceptor modulation could inform future antipsychotic development.